{"success":true,"data":{"pressRelease":{"id":"164306","rtpr_id":"nPre34G6ta-20261008","ticker":"IP40","exchange":"","all_tickers":["IP40"],"title":"VALITIC™ Launches Direct-to-Consumer Website, Laying Groundwork for U.S. Holiday Campaign","author":"PR Newswire","published_at":"2026-10-08T12:30:00.481Z","article_body":"VALITIC™ Launches Direct-to-Consumer Website, Laying Groundwork for U.S.\nHoliday Campaign\nPR Newswire\n\nHERZLIYA, Israel and CALGARY, AB, Oct. 8, 2026\n\nProducts now available at ValiticBeauty.com, expanding the brand beyond Amazon\nahead of a larger holiday-season launch\n\nHERZLIYA, Israel and CALGARY, AB, Oct. 8, 2026 /PRNewswire/ -- Innocan Pharma\nCorporation (CSE: INNO) (OTCQB: INNPF) (\"Innocan\" or the \"Company\"), through\nits consumer wellness subsidiary B.I. Sky Global Ltd. (\"B.I. Sky\"), is pleased\nto announce that VALITIC™ products are now available for direct purchase on\nthe brand's official website, ValiticBeauty.com.\n\n\nVALITIC™ is a consumer skincare and personal care brand with an established\npresence on Amazon, supported by strong consumer engagement, thousands of\ncustomer reviews and growing visibility across beauty and personal care\ncategories.\n\nThe brand is now expanding its U.S. presence through its own\ndirect-to-consumer (DTC) website, providing consumers with a new way to\ndiscover and purchase VALITIC™ products while enabling a direct relationship\nwith customers. The initial launch will allow B.I. Sky Global to optimize the\nplatform and customer experience ahead of a larger marketing and promotional\ncampaign planned for the 2026 holiday shopping season.\n\nThe DTC platform complements VALITIC™'s Amazon business and supports B.I.\nSky Global's broader strategy to build a scalable, multi-channel U.S. consumer\nwellness business.\n\n\"Launching our own website gives us a direct connection with VALITIC™\ncustomers and an additional channel for growth,\" said Roni Kamhi, CEO of B.I.\nSky Global & COO of Innocan \"We are using this initial phase to optimize the\nplatform and prepare for a larger-scale holiday launch.\"\n\nVALITIC™ products are available now at: ValiticBeauty.com\n(https://valiticbeauty.com/)\n\nIris Bincovich, CEO of Innocan Pharma, added: \"Building a direct-to-consumer\nchannel alongside Amazon reduces reliance on a single marketplace and gives us\nmore ways to grow sales. Combined with the traction VALITIC™ has already\nachieved, we believe this expanded distribution strategy provides a strong\nfoundation for continued growth in the U.S. market as we head into the holiday\nseason.\"\n\nAbout Innocan:\n\nInnocan is an innovator in the pharmaceuticals and wellness sectors. In the\nwellness sector, Innocan develops and markets a wide portfolio of\nhigh-performance self-care and beauty products to promote a healthier\nlifestyle. Under this segment Innocan carries on business through its\n60%-owned subsidiary, B.I. Sky Global Ltd., which focuses on advanced,\ntargeted online sales.\n\nwww.innocanpharma.com \n\nContact Information:\n\nFor Innocan Pharma Corporation:\nIris Bincovich, CEO\n+1 516-210-4025\n+972-54-3012842\n+44 20 3769 9377\ninfo@innocanpharma.com\n\nNEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER\nHAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS\nRELEASE.\n\nCaution Regarding Forward-Looking Information\n\nCertain information set forth in this news release, including, without\nlimitation, statements regarding the planned holiday-season launch and related\nmarketing and promotional initiatives, the expected contribution of the\ndirect-to-consumer channel alongside Amazon and other online retail channels,\nand the anticipated growth of the VALITIC™ brand in the U.S. market, is\nforward-looking information within the meaning of applicable securities laws.\nBy its nature, forward-looking information is subject to numerous risks and\nuncertainties, some of which are beyond Innocan's control. The forward-looking\ninformation contained in this news release is based on certain key\nexpectations and assumptions made by Innocan, including expectations and\nassumptions concerning the anticipated benefits of the products, satisfaction\nof regulatory requirements in various jurisdictions and satisfactory\ncompletion of production and distribution arrangements.\n\nForward-looking information is subject to various risks and uncertainties that\ncould cause actual results and experience to differ materially from the\nanticipated results or expectations expressed in this news release. The key\nrisks and uncertainties include but are not limited to: global and local\n(national) economic, political, market and business conditions; governmental\nand regulatory requirements and actions by governmental authorities; and\npotential disruption of relationships with suppliers, manufacturers,\ncustomers, business partners and competitors. There are also risks that are\ninherent in the nature of product distribution, including import/export\nmatters and the failure to obtain any required regulatory and other approvals\n(or to do so in a timely manner). The anticipated timeline for entry to\nmarkets may change for a number of reasons, including the inability to secure\nnecessary regulatory requirements, or the need for additional time to conclude\nand/or satisfy the manufacturing and distribution arrangements. As a result of\nthe foregoing, readers should not place undue reliance on the forward-looking\ninformation contained in this news release. A comprehensive discussion of\nother risks that impact Innocan can be found in Innocan's public reports and\nfilings which are available under Innocan's profile at www.sedarplus.ca.\n\nReaders are cautioned that undue reliance should not be placed on\nforward-looking information as actual results may vary materially from the\nforward-looking information. Innocan does not undertake to update, correct or\nrevise any forward-looking information as a result of any new information,\nfuture events or otherwise, except as may be required by applicable law.\n\n\nView original content to download\nmultimedia:https://www.prnewswire.co.uk/news-releases/valitic-launches-direct-to-consumer-website-laying-groundwork-for-us-holiday-campaign-302902357.html\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS2005057/PIC-PR.jpg?id=OA2994574\nhttps://mmx.prnewswire.com/media/MS1626040/Innocan-Pharma-Logo.jpg?id=OA2994575\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPre34G6ta-20261008","title":"VALITIC™ Launches Direct-to-Consumer Website, Laying Groundwork for U.S. Holiday Campaign","author":"PR Newswire","ticker":"IP40","created":"2026-10-08T12:30:00.481Z","tickers":["IP40"],"exchange":"","article_body":"VALITIC™ Launches Direct-to-Consumer Website, Laying Groundwork for U.S.\nHoliday Campaign\nPR Newswire\n\nHERZLIYA, Israel and CALGARY, AB, Oct. 8, 2026\n\nProducts now available at ValiticBeauty.com, expanding the brand beyond Amazon\nahead of a larger holiday-season launch\n\nHERZLIYA, Israel and CALGARY, AB, Oct. 8, 2026 /PRNewswire/ -- Innocan Pharma\nCorporation (CSE: INNO) (OTCQB: INNPF) (\"Innocan\" or the \"Company\"), through\nits consumer wellness subsidiary B.I. Sky Global Ltd. (\"B.I. Sky\"), is pleased\nto announce that VALITIC™ products are now available for direct purchase on\nthe brand's official website, ValiticBeauty.com.\n\n\nVALITIC™ is a consumer skincare and personal care brand with an established\npresence on Amazon, supported by strong consumer engagement, thousands of\ncustomer reviews and growing visibility across beauty and personal care\ncategories.\n\nThe brand is now expanding its U.S. presence through its own\ndirect-to-consumer (DTC) website, providing consumers with a new way to\ndiscover and purchase VALITIC™ products while enabling a direct relationship\nwith customers. The initial launch will allow B.I. Sky Global to optimize the\nplatform and customer experience ahead of a larger marketing and promotional\ncampaign planned for the 2026 holiday shopping season.\n\nThe DTC platform complements VALITIC™'s Amazon business and supports B.I.\nSky Global's broader strategy to build a scalable, multi-channel U.S. consumer\nwellness business.\n\n\"Launching our own website gives us a direct connection with VALITIC™\ncustomers and an additional channel for growth,\" said Roni Kamhi, CEO of B.I.\nSky Global & COO of Innocan \"We are using this initial phase to optimize the\nplatform and prepare for a larger-scale holiday launch.\"\n\nVALITIC™ products are available now at: ValiticBeauty.com\n(https://valiticbeauty.com/)\n\nIris Bincovich, CEO of Innocan Pharma, added: \"Building a direct-to-consumer\nchannel alongside Amazon reduces reliance on a single marketplace and gives us\nmore ways to grow sales. Combined with the traction VALITIC™ has already\nachieved, we believe this expanded distribution strategy provides a strong\nfoundation for continued growth in the U.S. market as we head into the holiday\nseason.\"\n\nAbout Innocan:\n\nInnocan is an innovator in the pharmaceuticals and wellness sectors. In the\nwellness sector, Innocan develops and markets a wide portfolio of\nhigh-performance self-care and beauty products to promote a healthier\nlifestyle. Under this segment Innocan carries on business through its\n60%-owned subsidiary, B.I. Sky Global Ltd., which focuses on advanced,\ntargeted online sales.\n\nwww.innocanpharma.com \n\nContact Information:\n\nFor Innocan Pharma Corporation:\nIris Bincovich, CEO\n+1 516-210-4025\n+972-54-3012842\n+44 20 3769 9377\ninfo@innocanpharma.com\n\nNEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER\nHAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS\nRELEASE.\n\nCaution Regarding Forward-Looking Information\n\nCertain information set forth in this news release, including, without\nlimitation, statements regarding the planned holiday-season launch and related\nmarketing and promotional initiatives, the expected contribution of the\ndirect-to-consumer channel alongside Amazon and other online retail channels,\nand the anticipated growth of the VALITIC™ brand in the U.S. market, is\nforward-looking information within the meaning of applicable securities laws.\nBy its nature, forward-looking information is subject to numerous risks and\nuncertainties, some of which are beyond Innocan's control. The forward-looking\ninformation contained in this news release is based on certain key\nexpectations and assumptions made by Innocan, including expectations and\nassumptions concerning the anticipated benefits of the products, satisfaction\nof regulatory requirements in various jurisdictions and satisfactory\ncompletion of production and distribution arrangements.\n\nForward-looking information is subject to various risks and uncertainties that\ncould cause actual results and experience to differ materially from the\nanticipated results or expectations expressed in this news release. The key\nrisks and uncertainties include but are not limited to: global and local\n(national) economic, political, market and business conditions; governmental\nand regulatory requirements and actions by governmental authorities; and\npotential disruption of relationships with suppliers, manufacturers,\ncustomers, business partners and competitors. There are also risks that are\ninherent in the nature of product distribution, including import/export\nmatters and the failure to obtain any required regulatory and other approvals\n(or to do so in a timely manner). The anticipated timeline for entry to\nmarkets may change for a number of reasons, including the inability to secure\nnecessary regulatory requirements, or the need for additional time to conclude\nand/or satisfy the manufacturing and distribution arrangements. As a result of\nthe foregoing, readers should not place undue reliance on the forward-looking\ninformation contained in this news release. A comprehensive discussion of\nother risks that impact Innocan can be found in Innocan's public reports and\nfilings which are available under Innocan's profile at www.sedarplus.ca.\n\nReaders are cautioned that undue reliance should not be placed on\nforward-looking information as actual results may vary materially from the\nforward-looking information. Innocan does not undertake to update, correct or\nrevise any forward-looking information as a result of any new information,\nfuture events or otherwise, except as may be required by applicable law.\n\n\nView original content to download\nmultimedia:https://www.prnewswire.co.uk/news-releases/valitic-launches-direct-to-consumer-website-laying-groundwork-for-us-holiday-campaign-302902357.html\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS2005057/PIC-PR.jpg?id=OA2994574\nhttps://mmx.prnewswire.com/media/MS1626040/Innocan-Pharma-Logo.jpg?id=OA2994575\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-08T12:30:00.690196079Z","server_sent_at_ms":1791462600690},"received_at":"2026-10-08T12:30:00.746Z","source_url":null},"analysis":{"id":"152717","press_release_id":"164306","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"Innocan Pharma, through its 60%-owned subsidiary B.I. Sky Global, announced that VALITIC skincare products are now available for direct purchase at ValiticBeauty.com, expanding the brand beyond Amazon.\n\nThe initial launch phase will be used to optimize the platform ahead of a larger marketing and promotional campaign planned for the 2026 holiday shopping season.\n\nManagement says the DTC channel reduces reliance on a single marketplace and supports a multi-channel U.S. consumer wellness strategy; no sales or revenue figures were disclosed.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Modest channel expansion for VALITIC brand -- watch holiday-season DTC traction for a real read."},"keyFigures":{"customDimensions":{"subsidiary_ownership":"60%"}},"quotedText":"Building a direct-to-consumer channel alongside Amazon reduces reliance on a single marketplace and gives us more ways to grow sales.","namedEntities":{"people":[{"name":"Roni Kamhi","role":"CEO of B.I. Sky Global & COO of Innocan"},{"name":"Iris Bincovich","role":"CEO of Innocan Pharma"}],"products":["VALITIC","ValiticBeauty.com"],"companies":[{"name":"Innocan Pharma Corporation","ticker":"INNPF","relationship":"parent filer"},{"name":"B.I. Sky Global Ltd.","relationship":"60%-owned consumer wellness subsidiary"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Launch of a DTC website for the VALITIC skincare brand via 60%-owned subsidiary B.I. Sky Global is a modest channel-expansion step, not a revenue-moving event; no financial figures disclosed."},"tickerRelevance":{"others":[{"ticker":"INNO","relevance":"mentioned"},{"ticker":"INNPF","relevance":"mentioned"}],"primary":"IP40"},"globalImportance":15,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"routine-channel-expansion","subsidiaryEvent":true,"noFinancialsDisclosed":true}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Innocan Pharma, through its 60%-owned subsidiary B.I. Sky Global, announced that VALITIC skincare products are now available for direct purchase at ValiticBeauty.com, expanding the brand beyond Amazon.\n\nThe initial launch phase will be used to optimize the platform ahead of a larger marketing and promotional campaign planned for the 2026 holiday shopping season.\n\nManagement says the DTC channel reduces reliance on a single marketplace and supports a multi-channel U.S. consumer wellness strategy; no sales or revenue figures were disclosed.","key_figures":{"customDimensions":{"subsidiary_ownership":"60%"}},"named_entities":{"people":[{"name":"Roni Kamhi","role":"CEO of B.I. Sky Global & COO of Innocan"},{"name":"Iris Bincovich","role":"CEO of Innocan Pharma"}],"products":["VALITIC","ValiticBeauty.com"],"companies":[{"name":"Innocan Pharma Corporation","ticker":"INNPF","relationship":"parent filer"},{"name":"B.I. Sky Global Ltd.","relationship":"60%-owned consumer wellness subsidiary"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-08T12:30:06.451Z","global_importance":15,"audience_relevance":12,"importance_components":{"tickerTier":"micro-cap","eventGravity":"routine-channel-expansion","subsidiaryEvent":true,"noFinancialsDisclosed":true}},"durationMs":5663,"modelName":"glm-5.3-flashx"}}